Predictors of nursing home placement in Huntington disease.
about
Huntington's disease: a clinical review.Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderUtilisation of Healthcare and Associated Services in Huntington's disease: a data mining studyDeterminants of functional disability in Huntington's disease: role of cognitive and motor dysfunctionAn International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's DiseaseThe impact of different types of assistive devices on gait measures and safety in Huntington's diseaseIrritability in pre-clinical Huntington's diseaseA small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.Neuropsychiatric Burden in Huntington's Disease.Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington's Disease.Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease.Gait in Huntington's disease and the stride length-cadence relationshipCurrent Pharmacological Approaches to Reduce Chorea in Huntington's Disease.A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings.Huntington's Disease and Striatal Signaling.Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.Palliative care provision in Huntington's disease.Stalking and Huntington's disease: a neurobiological link?The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.Characterisation of aggression in Huntington's disease: rates, types and antecedents in an inpatient rehabilitation setting.Falls and gait disturbances in Huntington's disease.Exploring the Validity of the Short Version of the Problem Behaviours Assessment (PBA-s) for Huntington's disease: A Rasch Analysis.Factors contributing to institutionalization in patients with Huntington's disease.Huntington's Disease: Characteristics of Fallers.Physical therapy in Huntington's disease--toward objective assessments?Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease.What effect does a structured home-based exercise programme have on people with Huntington's disease? A randomized, controlled pilot study.Client and therapist views on exercise programmes for early-mid stage Parkinson's disease and Huntington's disease.Reliability of spatiotemporal gait outcome measures in Huntington's disease.Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer.Functional brain changes underlying irritability in premanifest Huntington's disease.Survival of Huntington's disease patients in Serbia: longer survival in female patients.Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study.Physical Therapy and Exercise Interventions in Huntington's Disease: A Mixed Methods Systematic Review.Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length.Huntington diseaseIrritability in Huntington's Disease: Factor Analysis of Snaith's Irritability ScaleThe Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
P2860
Q21202876-18146E2E-A35D-4D71-BE48-B85AD8262E2AQ24626017-0AFA96FC-7DEC-4C75-87FE-83BCDD7F94E4Q24630195-DDACAF1C-3888-404F-9D47-F003CE913BB7Q26866192-819148E9-53ED-40DF-B89A-2378D1C01A08Q28476791-A40256CE-D735-4D8C-B408-9A3F914D39BFQ28732004-DCA46026-A157-4679-8757-C1AA07334B37Q33604313-DBA55880-B4CD-478B-A70D-57B1CBBFA37BQ33640604-5A36DF64-48FF-4FF1-8D15-511510A501FEQ33831793-EE584B47-EE99-4A17-8125-4F3F36237C0EQ34050993-ECCA9907-4D28-4725-A9B5-EC7EB0BA216DQ34208993-353EE087-AD8E-4A64-848A-5BC1EDAA0CF7Q34308962-D95AD63E-E2CF-4676-92C5-9017D6DD1D5CQ34547558-FFEDE404-E37A-497F-8A9B-D8A2A2524E99Q35230831-CD4B9A62-A59B-47DC-B648-CBDA15519937Q35286098-B39F13BA-6F85-4DD6-8765-38F31383CDF5Q35356604-378670DC-EE85-41F1-91E9-0140B87FF444Q36823634-03920AD0-EF24-44A9-A193-5D020BC246D6Q36903020-E08642B6-CEFC-4F78-B11E-F7CB5E68BF90Q38824416-F590A020-FDF4-4062-9418-C3D0C6492212Q38978771-FAFF7D7D-8307-4176-9A7D-86169FEB516EQ40107701-34F62536-6A38-4777-B9F4-DE441B31C7FFQ40118236-BA5A5C39-E92B-46F1-8DB2-4A498E669D25Q43740759-52058EFF-9AB8-4D4F-8F79-71590F89309AQ44032095-65588BEF-8AB5-4A57-9C20-F13AA10C57A1Q44739587-FF3311E5-203C-44D1-81AF-5479402FC9CCQ45289317-AF07B7FB-D974-4655-AAB3-D51C99AF8EFFQ45292050-7E686808-32BE-4F7F-A9FB-919AC4FE3246Q45295693-E92910D0-CC2C-43C0-AE05-5F8BD5455A03Q45296631-9F42F965-8953-4708-81BA-D1E8B37764ACQ45304182-A55FB2AF-545B-4A9B-8BD9-C85E03F671E1Q45305191-488631E9-D621-40B9-90DE-94B296231B77Q45305756-DD8C2F02-49B4-463F-AF20-1FC32DDC9C6DQ45305946-F71DA1E8-85CF-4563-9E1F-F12F78D14451Q47158264-7780A766-016E-4EC6-A149-B9880BFEFE57Q48147203-4F0BF70E-2F43-4611-B289-D75DC6C30D5FQ56083219-06990A81-D70B-49F6-B2C5-77154F11E314Q57554066-355C912D-E33E-4A35-B351-31325C77259BQ59136469-D936353C-F575-44C7-B291-8FBC316495ED
P2860
Predictors of nursing home placement in Huntington disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Predictors of nursing home placement in Huntington disease.
@en
Predictors of nursing home placement in Huntington disease.
@nl
type
label
Predictors of nursing home placement in Huntington disease.
@en
Predictors of nursing home placement in Huntington disease.
@nl
prefLabel
Predictors of nursing home placement in Huntington disease.
@en
Predictors of nursing home placement in Huntington disease.
@nl
P2093
P1433
P1476
Predictors of nursing home placement in Huntington disease.
@en
P2093
Huntington Study Group
I Shoulson
V L Wheelock
P304
P356
10.1212/01.WNL.0000052992.58107.67
P407
P577
2003-03-01T00:00:00Z